FDA approves four-in-one HIV pill

The U.S. Food and Drug Administration on Monday approved a once-a-day AIDS medicine that combines four drugs in one pill and is produced by Gilead Sciences, Inc.

The drug is designed to treat HIV-1 infection in adults who have never been treated for HIV infection, according to the FDA.

Brand-named Stribild, the pill contains two previously approved HIV drugs plus two new drugs.

“Through continued research and drug development, treatment for those infected with HIV has evolved from multi-pill regimens to single-pill regimens,” Dr. Edward Cox, director of the Office of Antimicrobial Products in FDA’s Center for Drug Evaluation and Research said in a statement. “New combination HIV drugs like Stribild help simplify treatment regimens.” A link to the FDA statement is here.

The Centers for Disease Control and Prevention said in its most recent yearly report on HIV/AIDS that New Jersey and Pennsylvania were among the top 10 states in the number of new cases being diagnosed. A link to the CDC report is here.

Earlier this year, the FDA approved the first over-the-counter, at-home test for HIV, which is made by Orasure of Bethlehem, Pa. A link to the Inquirer story on that approval is here.

The Kaiser Family Foundation HIV/AIDS Fact Sheet from July of 2012 is here.